TUSSILAGO PETASITES — all Canadian products
7 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is TUSSILAGO PETASITES, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00587117 | BRONCHITIS TEA | 3 WAY HERBS LTD. | Tea (Herbal) | Oral | TUSSILAGO PETASITES 25 %; HOREHOUND 25 %; HYSSOP 20 %; ANISE 10 %; GLYCYRRHIZA GLABRA 10 %; ALTHAEA OFFICINALIS 10 % | Cancelled Post Market | |
| 02063034 | FARFARA-INJEEL FORTE LIQ (4D,12D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | Oral | TUSSILAGO PETASITES 4 D | Cancelled Post Market | |
| 02063026 | FARFARA-INJEEL LIQ (10D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | Oral | TUSSILAGO PETASITES 10 D | Cancelled Post Market | |
| 00256374 | FLORA HERBTEA BRONCHIAL HERB TONIC TEA | FLORA MANUFACTURING AND DISTRIBUTING LTD. | Tea (Herbal) | Oral | TUSSILAGO PETASITES 60 %; PRIMROSE 10 %; GNAPHALIUM POLYCEPHALUM 10 %; CALENDULA 8 %; ACACIA 5 %; ANISE 3 %; POPPY 3 %; MALLOW 1 % | Cancelled Post Market | |
| 00445436 | LAPIDAR 16 TAB | SWISS HERBAL REMEDIES LTD. | Tablet | Oral | TUSSILAGO PETASITES 30 MG; WILD THYME 28 MG; ALTHAEA OFFICINALIS 33 MG; GLYCYRRHIZA GLABRA 28 MG; CETRARIA ISLANDICA 28 MG | Cancelled Post Market | |
| 01950258 | TUSSILAGO FARFARA GRANULE(1CH-30CH) | HOMEOCAN INC. | Tablet | Oral | TUSSILAGO PETASITES 1 CH | Cancelled Post Market | |
| 01950231 | TUSSILAGO PETASITES GRANULE(1CH-30CH) | HOMEOCAN INC. | Tablet | Oral | TUSSILAGO PETASITES 1 CH | Cancelled Post Market |
Browse other molecules: